Cite
HARVARD Citation
Riche, D. et al. (n.d.). Resistant Nonalcoholic Fatty Liver Disease Amelioration With Rosuvastatin and Pioglitazone Combination Therapy in a Patient With Metabolic Syndrome. Annals of pharmacotherapy. pp. 137-141. [Online].